Загрузка...
Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer
AIM: The use of bevacizumab in combination therapy is an emerging trend in metastatic colorectal cancer treatment. However, the clinical value of different combination types remains under debate. Thus, a meta-analysis of randomized controlled trials (RCTs) comparing bevacizumab-based combination the...
Сохранить в:
| Опубликовано в: : | Onco Targets Ther |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6287670/ https://ncbi.nlm.nih.gov/pubmed/30584320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S171724 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|